Company intelligence / Profile preview
cecava
Emeryville, California, USAcecava.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Cecava is a biotechnology company focused on the development of next-generation personalized cancer vaccines. The company leverages advanced computational biology and machine learning to identify patient-specific neoantigens that can be targeted to elicit a robust T-cell response. Founded by leaders in the immunotherapy space, Cecava aims to overcome the challenges of current vaccine platforms to provide more effective treatments for patients with various solid tumors. The company's approach integrates high-fidelity sequencing with proprietary algorithms to design vaccines tailored to the unique genetic profile of an individual's cancer.
- Therapeutic areas
- Oncology
- Modalities
- VaccinemRNA-based drugs
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on cecava.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cecava.